Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTH1R | Q03431 | 9/20 | 0.55 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.54 |
| ▸ | CDK2 | P24941 | 2/20 | 0.54 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.54 |
| ▸ | CCKBR | P32239 | 1/20 | 0.52 |
| ▸ | GLP1R | P43220 | 1/20 | 0.52 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.51 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.51 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.51 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29350082 | 0.85 | OPRL1 (0.61) | PTH1RCCNA2CDK2CCNA1CCKBR | |
| SCHEMBL29352003 | 0.84 | CCNA2 (0.57) | PTH1RCCNA2CDK2CCNA1OPRL1 | |
| SCHEMBL31104924 | 0.84 | GLP1R (0.66) | PTH1RCCKBRGLP1RCRHR1CRHR2 | |
| SCHEMBL31104935 | 0.84 | GLP1R (0.70) | PTH1RCCKBRGLP1RCRHR1CRHR2 | |
| SCHEMBL30640630 | 0.84 | GLP1R (0.70) | PTH1RCCKBRGLP1RCRHR1CRHR2 | |
| Magainin 2 SCHEMBL29374652 | 0.83 | PTH1R (0.66) | PTH1RCCKBRGLP1RSLC2A1 | |
| SCHEMBL29736049 | 0.83 | CCNA2 (0.65) | PTH1RCCNA2CDK2CCNA1 | |
| SCHEMBL30633102 | 0.83 | PTH1R (0.61) | PTH1RCCKBRGLP1RSLC2A1 | |
| SCHEMBL29419646 | 0.83 | CCNA2 (0.58) | PTH1RCCNA2CDK2CCNA1 | |
| SCHEMBL29389123 | 0.82 | PTH1R (0.63) | PTH1RGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118324870-A | Improved peptide drugs for insulin resistance | 梅德瑞斯糖尿病有限责任公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-117903257-A | Improved peptide drugs for insulin resistance | 梅德瑞斯糖尿病有限责任公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-117582516-A | Improved peptide drugs against insulin resistance | 梅德瑞斯糖尿病有限责任公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-117180445-A | Improved peptide drugs against insulin resistance | 梅德瑞斯糖尿病有限责任公司 | 2023-12-08 | — | — | CN | disclosed |
| WO-2023128419-A1 | METHOD FOR SCREENING COLORECTAL CANCER AND COLORECTAL POLYPS OR ADVANCED ADENOMAS AND APPLICATION THEREOF | 주식회사 이노제닉스 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023128429-A1 | METHOD FOR SCREENING COLORECTAL CANCER AND ADVANCED ADENOMA, AND APPLICATION THEREOF | 주식회사 이노제닉스 | 2023-07-06 | — | — | WO | disclosed |
| CN-112410381-B | Method for producing epsilon-polylysine and hydrochloride thereof by rapid fermentation | 郑州拜纳佛生物工程股份有限公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-109477839-B | Method for measuring glycated albumin | 旭化成制药株式会社 | 2022-06-14 | — | — | CN | disclosed |
| CN-114181388-A | Method for extracting polylysine from fermentation liquor | 河北圣雪大成制药有限责任公司 | 2022-03-15 | — | — | CN | disclosed |